SNDXSyndax Pharmaceuticals Inc
19.65USD-5.39%Mkt Cap: 1.74B $P/E: —3d ago
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.74B $
Enterprise Value1.80B $
Revenue (TTM)252.25M $
Gross Profit165.38M $
Net Income (TTM)-285.42M $
Revenue/Share2.873 USD
Last Price19.65 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees298
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS87164F1057
Valuation
P/E (Trailing)—
P/E (Forward)-26.63
PEG—
EV/EBITDA-9.26
EV/Revenue7.13
P/S6.99
P/B116.86
EPS (TTM)-2.39
EPS (Forward)-0.74
52W Range
12.9953% of range25.59
52W High25.59 USD
52W Low12.99 USD
Profitability
Gross Margin95.96%
Oper. Margin-54.95%
EBITDA Margin-76.97%
Profit Margin-165.60%
ROE-441.62%
ROA-53.88%
Growth
Revenue Growth91.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-322.98M $
CapEx (TTM)187.00K $
FCF Margin-59.50%
FCF Yield-8.62%
Net Debt35.12M $
Net Debt/EBITDA-0.18
Balance Sheet
Debt/Equity5.34
Current Ratio6.77
Quick Ratio6.29
Book Value/Sh0.1690 USD
Cash/Share6.207 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)37.91 USD
Upside (mean)+92.9%
Target Range26.00 USD – 57.00 USD
$26.00+92.9% to mean$57.00
# Analysts11
Ownership
Shares Out.88.61M
Float80.30M
Insiders1.69%
Institutions126.14%
Short Interest
Short Ratio13.4d
Short % Float25.82%
Short % Out.25.38%
Shares Short22.67M
Short (prev mo.)21.81M
Technical
SMA 5020.69 (-5.0%)
SMA 20020.75 (-5.3%)
Beta0.37
S&P 52W Chg18.16%
Avg Vol (30d)1.41M
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)45.4
MACD-0.2955
MACD Signal-0.3326
MACD Hist.+0.0371
BB Upper21.16 USD
BB Middle19.89 USD
BB Lower18.63 USD
BB Width12.75%
ATR (14)1.078 USD
Vol Ratio (20d)1.06x